日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

FLIPI24:一种用于新诊断滤泡性淋巴瘤的现代预后模型和临床试验富集工具

Maurer, Matthew J; Prochazka, Vit K; El-Galaly, Tarec Christoffer; Flowers, Christopher R; Villa, Diego; Bachy, Emmanuel; Cahn, Elliot J; Fournier, Marguerite; Larson, Melissa C; Dietrich, Caroline E; Jakobsen, Lasse Hjort; Ghesquières, Hervé; Kridel, Robert; Gandhi, Maher K; Cheah, Chan Y; Hawkes, Eliza A; Seymour, John F; Freeman, Ciara L; Clausen, Michael R; Wahlin, Björn E; Friedberg, Jonathan W; Casulo, Carla; Habermann, Thomas M; Wang, Yucai; Nastoupil, Loretta J; de Nully Brown, Peter; Belada, David; Janíková, Andrea; Mocikova, Heidi; Fürst, Tomáš; Feugier, Pierre; Tilly, Hervé; Haioun, Corinne; Davies, Andrew J; Cartron, Guillaume; Burack, Richard; Chihara, Dai; Martin, Peter; Cohen, Jonathon B; Lossos, Izidore S; Kahl, Brad S; Sehn, Laurie H; Smedby, Karin E; Salles, Gilles; Trneny, Marek; Link, Brian K; Morschhauser, Franck; Cerhan, James R

Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy

一线免疫化疗治疗滤泡性淋巴瘤患者的无事件生存期全基因组关联研究

Ghesquières, Hervé; Drouet, Youenn; Slager, Susan L; Morschhauser, Franck; Julia, Edith; Galimberti, Sara; Robinson, Dennis; Larson, Melissa C; Testard, Quentin; Tesson, Bruno; Deleuze, Jean-François; Boland, Anne; Thomas, Emilie; Lasset, Christine; Novak, Anne J; Xerri, Luc; Luminari, Stefano; Verney, Aurelie; Laurent, Camille; Rimsza, Lisa M; Habermann, Thomas M; Federico, Massimo; Link, Brian K; Salles, Gilles; Cerhan, James R

Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (CAPITAL)

Capivasertib (AZD5363) 是一种强效口服泛 AKT 抑制剂,用于治疗复发或难治性 B 细胞非霍奇金淋巴瘤患者的疗效和安全性 (CAPITAL)

Hodson, Daniel J; Shouse, Geoffrey; Shin, Ho-Jin; Salar, Antonio; Bobillo, Sabela; Ribrag, Vincent; Macpherson, Nicol A; Cordoba, Raul; Kim, Jin Seok; Guidez, Stephanie; Herrera, Alex F; Morschhauser, Franck; Colton, Dachelle; Izuzquiza, Macarena; Sambamurthy, Nisha; Munugalavadla, Veerendra; Vicente, Sergio; Gorgun, Gullu; Chen, Robert; Younes, Anas; Wang, Michael L

Health-related quality of life after second-line axi-cel in transplant-ineligible patients with large B-cell lymphoma

接受二线axi-cel治疗后不适合移植的大B细胞淋巴瘤患者的健康相关生活质量

Charton, Emilie; Anota, Amélie; Bachy, Emmanuel; Cartron, Guillaume; Gros, François-Xavier; Morschhauser, Franck; Oberic, Lucie; Gastinne, Thomas; Feugier, Pierre; Dulery, Remy; Thieblemont, Catherine; Joris, Magalie; Jardin, Fabrice; Choquet, Sylvain; Casasnovas, Olivier; Brisou, Gabriel; Cheminant, Morgane; Bay, Jacques-Olivier; Llamas Gutierrez, Francisco; Portugues, Cédric; Itti, Emmanuel; Palard-Novello, Xavier; Blanc-Durand, Paul; Al Tabaa, Yassine; Bailly, Clément; Laurent, Camille; Lemonnier, François; Houot, Roch

Risk stratification of patients with diffuse large B-cell lymphoma using plasma NMR-based metabolomics at diagnosis

利用基于血浆核磁共振代谢组学的诊断时代谢组学对弥漫性大B细胞淋巴瘤患者进行风险分层

Montagne, Aurélie; Bertho, Gildas; Papastergiou, Thomas; Chartier, Loïc; Ricci, Romain; Jardin, Fabrice; Ghesquières, Hervé; Rossi, Cédric; Morschhauser, Franck; Haioun, Corinne; Ribrag, Vincent; Feugier, Pierre; Brisou, Gabriel; Oberic, Lucie; Gaulard, Philippe; Giraud, Nicolas; Bennani, Younès; Thieblemont, Catherine; Baud, Véronique

Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry

CAR-T细胞疗法后侵袭性B细胞淋巴瘤晚期治疗失败:来自DESCAR-T注册研究的LYSA研究

Erbella, Federico; Bachy, Emmanuel; Cartron, Guillaume; Gat, Elodie; Manson, Guillaume; Morschhauser, Franck; Gros, Francois-Xavier; Roulin, Louise; Tessoulin, Benoit; Bories, Pierre; Tournilhac, Olivier; Ricard, Laure; Guidez, Stéphanie; Choquet, Sylvain; Casasnovas, Rene-Olivier; Brisou, Gabriel; Campidelli, Arnaud; Castilla-Llorente, Cristina; Jardin, Fabrice; Gyan, Emmanuel; Guffroy, Blandine; Abraham, Julie; Decroocq, Justine; Chauchet, Adrien; Joris, Magalie; Claves, Fabien; Carras, Sylvain; Guillerm, Gaëlle; Loschi, Michaël; Hermine, Olivier; Taguy-Schimidt, Aline; Le Gouill, Steven; Houot, Roch; Di Blasi, Roberta

Aiolos and Eos drive distinct human TH17 functional states

Aiolos 和 Eos 驱动不同的人类 TH17 功能状态

Cerboni, Silvia; Mohammadnezhad, Leila; Agrawal, Komal; Budida, Ramachandramouli; Papa, Ilenia; Gaggero, Silvia; Dulong, Joel; Cole, Anna; Mezger, Anja; Yan, Bingyu; Zhang, Zonghao; Israelsson, Elisabeth; Volkov, Petr; Li, Songyuan; Caceres, Eva F; Leprohon, Malo; Azgomi, Mojtaba Shekarkar; Cui, Yue; Salemio, Svitlana; Firth, Mike; Wigge, Leif; Rudin, Anna; Grindebacke, Hanna; Maresca, Marcello; Paulos, Chrystal; Morschhauser, Franck; Manier, Salomon; Kazemian, Majid; Laurence, Arian; Hühn, Michael; Gehrmann, Ulf; Tarte, Karin; Mitra, Suman

PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study

大型临床试验中患者报告结局(PRO)与临床医生报告的不良事件:POLARIX 3期研究结果

Thompson, Carrie; Trněný, Marek; Morschhauser, Franck; Salles, Gilles; Reagan, Patrick M; Hertzberg, Mark; Zhang, Huilai; Thieblemont, Catherine; Hu, Bei; Fonseca, Gustavo; Kim, Won Seog; Martelli, Maurizio; Mehta, Amitkumar; Singh, Avrita; Yan, Mark; Hirata, Jamie; Sugidono, Matthew; Lee, Calvin; Sharman, Jeff P; Mehta-Shah, Neha; Flowers, Christopher R; Tilly, Hervé; Chua, Neil; Casasnovas, René-Olivier; Miall, Fiona; Kim, Tae Min; Tsai, Xavier Cheng-Hong; Nasta, Sunita; Lee, Seung Tae; Friedberg, Jonathan W

Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study

Glofitamab治疗复发/难治性套细胞淋巴瘤:一项I/II期研究的结果

Phillips, Tycel Jovelle; Carlo-Stella, Carmelo; Morschhauser, Franck; Bachy, Emmanuel; Crump, Michael; Trněný, Marek; Bartlett, Nancy L; Zaucha, Jan; Wrobel, Tomasz; Offner, Fritz; Humphrey, Kathryn; Relf, James; Filézac de L'Etang, Audrey; Carlile, David J; Byrne, Ben; Qayum, Naseer; Lundberg, Linda; Dickinson, Michael

Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study

利索卡巴他根马拉鲁塞与二线复发/难治性大B细胞淋巴瘤标准治疗方案对比:来自随机III期TRANSFORM研究的3年随访结果

Kamdar, Manali; Solomon, Scott R; Arnason, Jon; Johnston, Patrick B; Glass, Bertram; Bachanova, Veronika; Ibrahimi, Sami; Mielke, Stephan; Mutsaers, Pim; Hernandez-Ilizaliturri, Francisco; Izutsu, Koji; Morschhauser, Franck; Lunning, Matthew; Chow, Victor A; Montheard, Sandrine; Santamaria, Josu; Colicino, Silvia; Ogasawara, Ken; Stepan, Lara; Liu, Fei Fei; Abramson, Jeremy S